Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

The management of multiple sclerosis: current and future therapies.

Stevenson VL, Thompson AJ.

Drugs Today (Barc). 1998 Mar;34(3):267-82.

PMID:
15094856
2.

Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis.

Hoogervorst EL, Kalkers NF, van Winsen LML, Uitdehaag BM, Polman CH.

Mult Scler. 2001 Oct;7(5):335-9.

PMID:
11724450
3.

Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life.

Bethoux F, Miller DM, Kinkel RP.

Mult Scler. 2001 Apr;7(2):137-42.

PMID:
11424634
4.

Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis.

Wiles CM, Newcombe RG, Fuller KJ, Shaw S, Furnival-Doran J, Pickersgill TP, Morgan A.

J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):174-9.

5.

Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis.

Freeman JA, Hobart JC, Langdon DW, Thompson AJ.

J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):150-6.

6.
7.

Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?

Freeman JA, Langdon DW, Hobart JC, Thompson AJ.

Neurology. 1999 Jan 1;52(1):50-6.

PMID:
9921848
8.
9.

Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.

Tremlett HL, Luscombe DK, Wiles CM.

J Neurol Neurosurg Psychiatry. 1998 Sep;65(3):362-5.

10.

The impact of inpatient rehabilitation on progressive multiple sclerosis.

Freeman JA, Langdon DW, Hobart JC, Thompson AJ.

Ann Neurol. 1997 Aug;42(2):236-44.

PMID:
9266735
11.

Assessment of motor function in people with multiple sclerosis.

De Souza LH, Ashburn A.

Physiother Res Int. 1996;1(2):98-111.

PMID:
9238727
12.

Prospective study of neurorehabilitation in multiple sclerosis.

Kidd D, Thompson AJ.

J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):423-4. No abstract available.

13.

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.

Barnes D, Hughes RA, Morris RW, Wade-Jones O, Brown P, Britton T, Francis DA, Perkin GD, Rudge P, Swash M, Katifi H, Farmer S, Frankel J.

Lancet. 1997 Mar 29;349(9056):902-6.

PMID:
9093250
15.

Multiple sclerosis: a literature review.

Miller CM, Hens M.

J Neurosci Nurs. 1993 Jun;25(3):174-9. Review.

PMID:
8340639
16.

Rehabilitation in multiple sclerosis.

Mertin J.

Ann Neurol. 1994;36 Suppl:S130-3. No abstract available.

PMID:
8017874
17.
18.

Maximum oxygen consumption and the ADAPT quality-of-life scale.

Daughton DM, Fix AJ, Kass I, Bell CW, Patil KD.

Arch Phys Med Rehabil. 1982 Dec;63(12):620-2. No abstract available.

PMID:
7149948
19.

The Barthel ADL Index: a reliability study.

Collin C, Wade DT, Davies S, Horne V.

Int Disabil Stud. 1988;10(2):61-3.

PMID:
3403500
20.

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Ware JE Jr, Sherbourne CD.

Med Care. 1992 Jun;30(6):473-83.

PMID:
1593914

Supplemental Content

Support Center